Skip to main content
. 2015 Jun 16;9:3099–3108. doi: 10.2147/DDDT.S85567

Figure 1.

Figure 1

Waterfall plot of the best tumor response in patients with metastatic colorectal cancer receiving reintroduction of oxaliplatin-based therapy.

Note: Tumor shrinkage was observed in 15/33 patients (45.5%).